Paul Tudor Jones Novo Cure LTD Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Novo Cure LTD stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 365,421 shares of NVCR stock, worth $6.59 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
365,421
Previous 184,359
98.21%
Holding current value
$6.59 Million
Previous $2.75 Million
107.52%
% of portfolio
0.04%
Previous 0.02%
Shares
20 transactions
Others Institutions Holding NVCR
# of Institutions
277Shares Held
73.2MCall Options Held
1.43MPut Options Held
832K-
Vanguard Group Inc Valley Forge, PA10MShares$181 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.08MShares$164 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.86MShares$160 Million0.03% of portfolio
-
State Street Corp Boston, MA3.36MShares$60.7 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.38MShares$42.9 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.89B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...